tiprankstipranks
Trending News
More News >
Tenon Medical, Inc. (TNON)
NASDAQ:TNON
US Market
Advertisement

Tenon Medical, Inc. (TNON) Earnings Dates, Call Summary & Reports

Compare
280 Followers

Earnings Data

Report Date
Mar 05, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.36
Last Year’s EPS
10.53
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects strong operational and strategic progress with record revenue growth, successful integration of acquisitions, and key product launches. However, challenges persist with increased operating expenses and a notable net loss, although mitigated by improved gross profit margins and no outstanding debt.
Company Guidance
In the third quarter of 2025, Tenon Medical reported a record revenue of $1,200,000, marking a 32% increase year-over-year, driven by a surge in cadmium procedure volumes and the integration of the SciVantage portfolio. The quarter highlighted key milestones, including the strategic asset acquisition of the Symmetry and Symmetry Plus sacroiliac joint fusion technologies, which were immediately accretive to revenue. Operating expenses for the quarter rose to $4,200,000, influenced by increased sales and integration costs, while the net loss was recorded at $3,300,000 or $0.40 per share. The company ended the quarter with $3,400,000 in cash and no debt, subsequently bolstered by a $2,850,000 pipe financing. Key product developments included the full commercial launch of the Catamaran SE SI joint fusion system and FDA 510(k) clearance for the Symmetry Plus system. Clinical data reinforced the Catamaran system's efficacy, with significant improvements in patient outcomes, paving the way for broader adoption and payer coverage. As the company advances its strategic initiatives, it emphasizes physician education and commercial expansion, positioning itself for sustained growth.
Record Revenue Growth
Tenon Medical achieved record revenue of $1,200,000 for the third quarter of 2025, marking a 32% increase compared to the same period last year.
Successful Integration of SciVantage Acquisition
The integration of the SciVantage portfolio contributed meaningfully to top-line growth, with key members of the CyVantage leadership team joining Tenon, enhancing commercial execution and innovation.
Launch of Catamaran SE System
The full commercial launch of the Catamaran SE SI joint fusion system expanded the implant portfolio and strengthened Tenon's competitive position in the sacroiliac joint fusion market.
FDA Clearance for Symmetry Plus System
Achieved FDA 510(k) clearance for the Symmetry Plus SI joint fusion system, introducing advancements like 3D printed titanium implants and a simplified bone graft delivery system.
Strong Clinical Data
Clinical trials showed statistically significant improvements in pain and disability scores, with 83% of patients showing evidence of fusion and high satisfaction rates.
Improved Financial Metrics
Gross profit for the quarter was $800,000, or 66% of revenue, compared to $400,000, or 47%, in the prior year quarter, with no outstanding debt by the quarter's end.

Tenon Medical, Inc. (TNON) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TNON Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 05, 2026
2025 (Q4)
-0.36 / -
10.53
Nov 13, 2025
2025 (Q3)
-0.37 / -0.40
-3.6388.98% (+3.23)
Aug 13, 2025
2025 (Q2)
-0.47 / -0.36
-8.1695.59% (+7.80)
May 13, 2025
2025 (Q1)
-0.99 / -1.01
-1089.90% (+8.99)
Mar 20, 2025
2024 (Q4)
-3.77 / 10.53
3.76180.05% (+6.77)
Nov 13, 2024
2024 (Q3)
-6.16 / -3.63
-11.6868.92% (+8.05)
Aug 13, 2024
2024 (Q2)
-8.68 / -8.16
-26.469.09% (+18.24)
May 14, 2024
2024 (Q1)
-10.72 / -10.00
-34.470.93% (+24.40)
Mar 12, 2024
2023 (Q4)
-11.04 / 3.76
-56106.71% (+59.76)
Nov 14, 2023
2023 (Q3)
-22.40 / -11.68
-22.447.86% (+10.72)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TNON Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 13, 2025
$1.18$1.180.00%
Aug 13, 2025
$1.67$1.40-16.17%
May 13, 2025
$1.24$1.11-10.48%
Mar 20, 2025
$1.11$1.00-9.91%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Tenon Medical, Inc. (TNON) report earnings?
Tenon Medical, Inc. (TNON) is schdueled to report earning on Mar 05, 2026, After Close (Confirmed).
    What is Tenon Medical, Inc. (TNON) earnings time?
    Tenon Medical, Inc. (TNON) earnings time is at Mar 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TNON EPS forecast?
          TNON EPS forecast for the fiscal quarter 2025 (Q4) is -0.36.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis